Genomic variants within chromosome 14q32.32 regulate bone mass through MARK3 signaling in osteoblasts

Qian Zhang,Larry D. Mesner,Gina M. Calabrese,Naomi Dirckx,Zhu Li,Angela Verardo,Qian Yang,Robert J. Tower,Marie-Claude Faugere,Charles R. Farber,Thomas L. Clemens
DOI: https://doi.org/10.1172/jci142580
IF: 19.456
2021-04-01
Journal of Clinical Investigation
Abstract:Bone mineral density (BMD) is a highly heritable predictor of osteoporotic fracture. GWAS have identified hundreds of loci influencing BMD, but few have been functionally analyzed. In this study, we show that SNPs within a BMD locus on chromosome 14q32.32 alter splicing and expression of PAR-1a/microtubule affinity regulating kinase 3 (MARK3), a conserved serine/threonine kinase known to regulate bioenergetics, cell division, and polarity. Mice lacking <i>Mark3</i> either globally or selectively in osteoblasts have increased bone mass at maturity. RNA profiling from <i>Mark3</i>-deficient osteoblasts suggested changes in the expression of components of the Notch signaling pathway. <i>Mark3</i>-deficient osteoblasts exhibited greater matrix mineralization compared with controls that was accompanied by reduced <i>Jag1/Hes1</i> expression and diminished downstream JNK signaling. Overexpression of <i>Jag1</i> in <i>Mark3</i>-deficient osteoblasts both in vitro and in vivo normalized mineralization capacity and bone mass, respectively. Together, these findings reveal a mechanism whereby genetically regulated alterations in <i>Mark3</i> expression perturb cell signaling in osteoblasts to influence bone mass.
medicine, research & experimental
What problem does this paper attempt to address?